https://orcid.org/0000-0003-4551-6687
Current Duke Appointments & Affiliations
Chief of Hematologic Malignancies and Cellular Therapy
·
2024 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
James Wyngaarden Distinguished Professor of Medicine
·
2025 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Professor of Medicine
·
2020 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Professor of Integrative Immunobiology
·
2020 - Present
Integrative Immunobiology,
Basic Science Departments
Member of the Duke Cancer Institute
·
2013 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Scholarly Works
A More MAGICal Alogrithm in Acute GVHD.
Journal article Transplant Cell Ther · April 2024 Full text Link to item CiteFinancial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis.
Journal article JCO Oncol Pract · March 2024 PURPOSE: We investigated the prevalence of financial toxicity in a population undergoing hematopoietic cell transplantation (HCT) evaluation and measured its impact on post-transplant clinical and health-related quality-of-life outcomes. MATERIALS AND METH ... Full text Link to item CitePatient-reported treatment response in chronic graft-versus-host disease.
Journal article Haematologica · January 1, 2024 Chronic graft-versus-host disease (GvHD) treatment response is assessed using National Institutes of Health (NIH) Consensus Criteria in clinical trials, and by clinician assessment in routine practice. Patient-reported treatment response is central to the ... Full text Link to item CiteRecent Grants
Hematology & Transfusion Medicine
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1975 - 2031Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 20312/3 CTSA K12 Program at Duke University
ResearchMentor · Awarded by National Center for Advancing Translational Sciences · 2025 - 2030View All Grants
Education
Boston University, School of Medicine ·
1998
Ph.D.
Boston University ·
1998
M.D.